Eye Drop

Théa has agreed to purchase seven branded ophthalmic products from Akorn, according to a press release.

Vuity, an eye drop for the treatment of presbyopia, is now available, according to a press release from AbbVie.

Allergan, an AbbVie company, announced the FDA approval of the eye drop, Vuity, for the treatment of presbyopia.

More than a decade ago, the International Task Force Delphi Panel on Dry Eye identified autologous serum eye drops as a recommended treatment for patients with severe or chronic dry eye symptoms and/or moderate to marked staining.

Treating dry eye with 0.6% povidone-iodine eye drops in patients with damaged ocular surfaces was “safe and well tolerated,” according to data published the Journal of Ocular Pharmacology and Therapeutics.

The earlier we prepare patients for presbyopia — and reassure them that there are new treatment options on the horizon — the better.

Nyxol, an alpha 1/2 antagonist eye drop, helped reverse the effects of pharmacologically induced mydriasis in healthy subjects, according to a phase 3 study.

Chris Wroten, OD, presented an overview at this year’s SECO meeting covering a broad range of eye care technologies and treatments that became recently available or are quickly coming down the pipeline and may increase patient compliance.

Aerie Pharmaceuticals has completed enrollment in a phase 2b clinical trial investigating AR-15512 ophthalmic solution for dry eye disease, according to a press release.

Patients using a nose-pivoted drop delivery device experienced improved eye drop delivery and accuracy compared with a traditional eye drop delivery system.